Abstract
The benefits of assertive community treatment (ACT) on patients with severe mental disorders are well established over short or medium term. However, studies that investigate long term outcomes are remarkably scarce. Thus, this study aimed to evaluate patient’s long term clinical and psychosocial evolution after discharge from ACT. An assessment was conducted on 29 patients characterized by inpatient facilities heavy use and refusal of care, who were included in an ACT program 8.7 (SD = 0.7) years ago and discharged 6.3 (SD = 1.8) years ago. Results of the follow up showed decreased rates of hospitalizations and symptomatology, as well as sustained improvement in adherence to care, in quality of life and in social functioning. This data suggests that ACT programs can help refractory to care patients to gain clinical and psychosocial improvement and lay foundation for better long-term adherence to care. Results also suggest that ACT didn’t imply a lifetime treatment.
Similar content being viewed by others
References
Aagaard, J., & Kolbaek, P. (2016). Predictors of clinical outcome of assertive community treatment (ACT) in a rural area in Denmark: An observational Study with a two-Year follow-up. Community Mental Health Journal,52(8), 908–913.
Aagaard, J., & Muller-Nielsen, K. (2011). Clinical outcome of assertive community treatment (ACT) in a rural area in Denmark: A case-control study with a 2-year follow-up. Nordic Journal of Psychiatry,65(5), 299–305.
Aagaard, J., Tuszewski, B., & Kolbaek, P. (2016). Does assertive community treatment reduce the use of compulsory admissions? Archives of Psychiatric Nursing,31, 641–646.
Award, Gold. (1974). A community treatment program- Mendota Mental Health Institute, Madison, Wisconsin. Hospital & Community Psychiatry,25(10), 669–672.
Barker, S., Barron, N., McFarland, B. H., Bigelow, D. A., & Carnahan, T. A. (1994a). A community ability scale for chronically mentally ill consumers Part I: Reliability and validity. Community Mental Health Journal,30(4), 363–379.
Barker, S., Barron, N., McFarland, B. H., Bigelow, D. A., & Carnahan, T. A. (1994b). Community ability scale for chronically mentally ill consumers Part II: Applications. Community Mental Health Journal,30(5), 459–472.
Bassani, D. G., Dewa, C. S., Krupa, T., Aubry, T., Gehrs, M., Goering, P. N., et al. (2009). Factor structure of the Multnomah Community Abillity Scale—Longitudinal analysis. Psychiatry Research,167(1), 178–189.
Bond, G.R., Campbell, K., Evans, L.J., Gervey, R., Pascaris, A., Tice, S., …, & Revell, G. et al (2002). A scale to measure quality of supported employment for persons with severe mental illness. Journal of Vocational Rehabilitation, 17, 239–250.
Bonsack, C., Adam, L., Haefliger, T., Besson, J., & Conus, P. (2005). Difficult-to-engage patients: A specific target for time-limited assertive outreach in a Swiss setting. Canadian Journal of Psychiatry,50(13), 845–850.
Burns, T. (2010). The rise and fall of assertive community treatment? International Review of Psychiatry,22(2), 130–137.
Burns, T., Catty, J., Dash, M., Roberts, C., Lockwood, A., & Marshall, M. (2007). Use of intensive case management to reduce time in hospital in people with severe mental illness: A systematic review and meta-regression. BMJ,335(7615), 336.
Coldwell, C. M., & Bender, W. S. (2007). The effectiveness of assertive community treatment for homeless populations with severe mental illness: A meta-analysis. American Journal of Psychiatry,164(3), 393–399.
Corbière, M., Crocker, A. G., Lesage, A. D., Latimer, E., Ricard, N., & Mercier, C. (2002). Factor structure of the Multnomah community ability scale. Journal of Nervous Mental Disorders,190(6), 399–405.
Corrigan, P. W., Salzer, M., Ralph, R. O., Sangster, Y., & Keck, L. (2004). Examining the factor structure of the recovery assessment scale. Schizophrenia Bulletin,30(4), 1035–1041.
Dixon, L. (2000). Assertive community treatment: Twenty-five years of Gold. Psychiatric Services,51(6), 759–765.
Drake, R. E., Osher, F., Noordsy, D., Hurlbut, S., Teague, G., & Beaudett, M. (1990). Diagnosis of alcohol use disorder in schizophrenia. Schizophrenia Bulletin,16(1), 57–67.
Drake, R. E., & Wallach, M. (1989). Substance abuse among the chronic mentally ill. Hospital & Community Psychiatry,40(10), 1042–1046.
Drukker, M., Laan, W., Dreef, F., Driessen, G., Smeets, H., & Van Os, J. (2014). Can assertive community treatment remedy patients dropping out of treatment due to fragmented services? Community Mental Health Journal,50(4), 454–459.
Fialko, L., Garety, P. A., Kuipers, E., Dunn, G., Bebbington, P. E., Fowler, D., et al. (2008). A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophrenia Research,100(1–3), 53–59.
Glover, G. (2007). Adult mental health care in England. European Archives of Psychiatry and Clinical Neuroscience,257, 71–82.
Halling Hastrup, L., & Aagaard, J. (2015). Costs and outcome of assertive community treatment (ACT) in a rural area in Denmark: 4-year register-based follow-up. Nordic Journal of Psychiatry,69(2), 110–117.
Hoof, F., Knipsel, A., Schneider, J., Beeley, C., Aagaard, J., & Putten, M. (2011). Outpatient care and community support for persons with severe mental health problems. A comparison of national policies and system in Denmark, England and the Netherlands. Utrecht: Troimbos Institute.
Huguelet, P., Koellner, V., Boulgy, S., Nagalingum, K., Amani, S., Borras, L., et al. (2012). Effects of an assertive community program in patients with severe mental disorders and impact on their families. Psychiatry and Clinical Neurosciences,66, 328–336.
Killaspy, H., Bebbington, P., Blizard, R., Johnson, S., Nolan, F., & Pilling, S. (2006). The REACT study: Randomised evaluation of assertive community treatment in north London. BMJ,332, 815–820.
Killaspy, H., Kingett, S., & Bebbington, P. (2009). Randomised evaluation of assertive community treatment: 3-year outcomes. British Journal of Psychiatry,195, 81–82.
Killaspy, H., Mas-Exposito, L., Marston, L., & King, M. (2014). Ten year outcomes of participants in the REACT (Randomised Evaluation of Assertive Community Treatment in North London) Study. BMC Psychiatry,14, 296.
Kopelowicz, A., Ventura, J., Libermann, R. P., & Mintz, J. (2008). Consistency of brief psychiatric rating scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology,41(2), 77–84.
Lysaker, P. H., & Buck, K. D. (2008). Is recovery from schizophrenia possible? An overview of concepts, evidence, and clinical implications. Primary Psychiatry,15(6), 60–65.
Marshall, M., & Lockwood, A. (2000). Assertive community treatment for people with severe mental disorders. Cochrane Library,2, CD001089.
Marshall, M., & Lockwood, A. (2010). Assertive community treatment for people with severe mental disorders. Revision. Cochrane Library,2, CD001089.
McHugo, G. J., Drake, R. E., Burton, H. L., & Ackerson, T. H. (1999). A scale for assessing the stages of substance treatment in persons with severe mental illness. Journal of Nervous Mental Disorders,183(12), 762–767.
Overall, J. E. R., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports,10, 799–812.
Ralph, O. R. (2000). Recovery. Psychiatric Rehabilitation Skills,4, 480–517.
Roe, D., Mashiach-Eizenberg, M., & Corrigan, P. (2012). Confirmatory analysis of the Brief Version of the Recovery Assessment Scale. Journal of Nervous Mental Disorders,200(10), 847–851.
Schmidt, S., Lange, M., Schöttle, D., Karow, A., Schimmelmann, B. G., & Lambert, M. (2018). Negative symptoms, anxiety, and depression as mechanisms of change of a 12-mothn trial of assertive community treatment as part of integrated care in patients with first-and multi-episode schizophrenia spectrum disorders (ACCESS I trial). European Archives of Psychiatry and Clinical Neurosciences,268(6), 593–602.
Schottle, D., Schimmelmann, B. G., & Karow, A. F. (2014). Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia spectrum and bipolar I disorders: The 24-month follow-up ACCESS II study. Journal of Clinical Psychiatry,75(12), 1371–1379.
Stein, L. I., & Santos, A. B. (1998). Assertive community treatment of persons with severe mental illness. New York: Norten.
Sytema, S., Wunderink, L., Bloemers, W., Roorda, L., & Wiersma, D. (2007). Assertive community treatment in the Netherlands: A randomized controlled trial. Acta Psychiatrica Scandinavica,116(2), 105–112.
Teague, G. B., Bond, G. R., & Drake, R. E. (1998). Program fidelity in assertive community treatment: Development and use of a measure. The American Journal of Orthopsychiatry,68(2), 216–232.
Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research,42(3), 241–247.
WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-Bref quality of life assessment. Psychological Medicine,28(3), 551–558.
Zemmour, K., Tinland, A., Boucekine, M., Girard, V., Loubière, S., Fond, G., … & Boyer, L. (2016) Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia. Results from the French Housing First experience. Scientific Reports, https://doi.org/10.1038/srep31598.
Acknowledgements
We would like to warmly thank all the staff of the Assertive Community Treatment Mobile Team of the Geneva University Hospitals (S. Boulgy, R. Claveria, T. Delachenal, S. Demski, JC Fayet, C. Lehmann Koell, D. Mariatti, A. Mignot, K. Nagalingum, JL. Sudreau, S.Wolf) as well as Mr A. Engelhorn for his private support in the baseline study.
Funding
The baseline study was partially supported by a private Grant (Mr A. Engelhorn).
Author information
Authors and Affiliations
Contributions
PH designed the study. SV drafted the manuscript, and PH and NP gave critical revision. LC and SV carried out the data acquisition. NP and SV performed the analysis. All authors provided critical feedback and gave final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Vidal, S., Perroud, N., Correa, L. et al. Assertive Community Programs for Patients with Severe Mental Disorders: Are Benefits Sustained After Discharge?. Community Ment Health J 56, 559–567 (2020). https://doi.org/10.1007/s10597-019-00513-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-019-00513-6